AnaSpec Introduces New FRET Technology Brochure

Released on: January 10, 2008, 9:02 am

Press Release Author: AnaSpec Inc.

Industry: Biotech

Press Release Summary: AnaSpec has developed a broad portfolio of products based on
fluorescence energy transfer (FRET) technology, most notably the SensoLyteT line of
high-performance assay kits.

Press Release Body: January 9, 2008 - San Jose, CA

Leveraging proprietary dye technologies, AnaSpec has developed a broad portfolio of
products based on fluorescence energy transfer (FRET) technology, most notably the
SensoLyteT line of high-performance assay kits. Showcasing this technology, AnaSpec
has announced the availability of its new FRET Technology Brochure.

The detection of proteases and screening of specific protease inhibitors are
critical factors in the discovery of potential drugs for the treatment and
management of protease-related diseases. In the last decade or so, the use of
fluorescence resonance energy transfer (FRET) technology has made the continuous
assay of protease activity and high throughput screening (HTS) of protease
inhibitors faster and easier.

AnaSpec's SensoLyteT line offers the industry's first and most sensitive collection
of long wavelength protease assay kits. Combining proprietary FRET technologies
with world-class peptide expertise, the SensoLyteT family demonstrates significantly
superior performance over traditional assay kits. The perfect overlap of absorption
and emission spectrums of the SensoLyteT FRET pairs allows for a level of
sensitivity that is as much as 40x greater.

AnaSpec's newly-released FRET Technology Brochure features:

. SensoLyteT protease assay kits for HTS of inhibitors or quantitation of HCV, HIV,
MMPs,  and -Secretases, Renin, TACE, ACE2, & WNV.
. Table of the different donor and acceptor molecules
. Listing of dye-labeled amino acids or resins that can be used as building blocks
. Concise guideline on how to design FRET peptides

Company Info

AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents (dyes, assay kits, & antibodies), and
combinatorial chemistry.
For more information, visit www.anaspec.com

References:
1. Puente, XS. et al. Nat. Rev. Genet. 4, 544 (2003).


Web Site: http://www.anaspec.com

Contact Details: 2149 O\'toole Ave.
San Jose, CA 95131
1-408-452-5055
ping@anaspec.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •